Krystal Biotech Inc (KRYS)
159.05
-2.99
(-1.85%)
USD |
NASDAQ |
Apr 24, 16:00
158.98
-0.06
(-0.04%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Quarterly): 778.64M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 778.64M |
| September 30, 2023 | 755.95M |
| June 30, 2023 | 653.11M |
| March 31, 2023 | 489.57M |
| December 31, 2022 | 522.23M |
| September 30, 2022 | 540.77M |
| June 30, 2022 | 559.18M |
| March 31, 2022 | 548.55M |
| December 31, 2021 | 593.58M |
| September 30, 2021 | 408.24M |
| June 30, 2021 | 418.54M |
| March 31, 2021 | 430.65M |
| December 31, 2020 | 292.08M |
| September 30, 2020 | 301.72M |
| Date | Value |
|---|---|
| June 30, 2020 | 309.70M |
| March 31, 2020 | 198.37M |
| December 31, 2019 | 202.91M |
| September 30, 2019 | 207.65M |
| June 30, 2019 | 198.29M |
| March 31, 2019 | 109.49M |
| December 31, 2018 | 113.23M |
| September 30, 2018 | 52.29M |
| June 30, 2018 | 45.27M |
| March 31, 2018 | 47.40M |
| December 31, 2017 | 49.47M |
| September 30, 2017 | 50.20M |
| June 30, 2017 | 3.393M |
| December 31, 2016 | 0.289M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
198.29M
Minimum
Jun 2019
778.64M
Maximum
Dec 2023
442.62M
Average
430.65M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
| Axsome Therapeutics Inc | 190.98M |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Catalyst Pharmaceuticals Inc | 387.88M |
| Ionis Pharmaceuticals Inc | 386.69M |
| Madrigal Pharmaceuticals Inc | 405.33M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 818.36M |
| Total Liabilities (Quarterly) | 39.71M |
| Current Ratio | 17.76 |